{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T08:13:49Z","timestamp":1788509629999,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["P\/552\/2016-17\/TDT(G)"],"award-info":[{"award-number":["P\/552\/2016-17\/TDT(G)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xphs.2026.104294","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:27:51Z","timestamp":1777073271000},"page":"104294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hot melt extrusion-driven cocrystallization of aceclofenac with nicotinamide: A strategy to enhance solubility, bioavailability, and therapeutic effect"],"prefix":"10.1016","volume":"115","author":[{"given":"Sneha Balu","family":"Govind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvis A.F.","family":"Martis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-7198","authenticated-orcid":false,"given":"Vaishali Ashish","family":"Shirsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104294_bib0001","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.70328","article-title":"Current perspectives on development and applications of cocrystals in the pharmaceutical and medical domain","author":"Chavan","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.xphs.2026.104294_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041161","article-title":"Cocrystals by design: a rational coformer selection approach for tackling the API problems","volume":"15","author":"Singh","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104294_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jpp\/rgad097","article-title":"Pharmaceutical co-crystals: a green way to enhance drug stability and solubility for improved therapeutic efficacy","volume":"76","author":"Chettri","year":"2024","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2026.104294_bib0004","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.apsb.2021.03.030","article-title":"Pharmaceutical cocrystals: a review of preparations, physicochemical properties and applications","volume":"11","author":"Guo","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2026.104294_bib0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.22270\/jddt.v8i6-s.2194","article-title":"Co-crystals: a review","volume":"8","author":"Chaudhari","year":"2018","journal-title":"J Drug Deliv Ther"},{"key":"10.1016\/j.xphs.2026.104294_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212045","article-title":"Prioritizing computational cocrystal prediction methods for experimental researchers: a review to find efficient, cost-effective, and user-friendly approaches","volume":"25","author":"Lemli","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2026.104294_bib0007","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/1061186X.2023.2300690","article-title":"Pharmaceutical cocrystals: a rising star in drug delivery applications","volume":"32","author":"Panzade","year":"2024","journal-title":"J Drug Target"},{"key":"10.1016\/j.xphs.2026.104294_bib0008","article-title":"Cocrystal of lutein with improved stability and bioavailability","author":"Zheng","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.xphs.2026.104294_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124596","article-title":"Polymorph selection of pharmaceutical cocrystals via bench-top and continuous production techniques","volume":"663","author":"O\u2019Sullivan","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104294_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.apsb.2018.09.008","article-title":"The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals","volume":"9","author":"Ren","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2026.104294_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121924","article-title":"Cocrystals of tuberculosis antibiotics: challenges and missed opportunities","volume":"623","author":"Salem","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104294_bib0012","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1039\/D3RA00750B","article-title":"Cocrystal of phloretin with isoniazid: preparation, characterization, and evaluation","volume":"13","author":"Lu","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104294_bib0013","article-title":"Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs","volume":"4","author":"Meng","year":"2022","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.xphs.2026.104294_bib0014","article-title":"Two novel palbociclib-resorcinol and palbociclib-orcinol cocrystals with enhanced solubility and dissolution rate","volume":"14","author":"Duan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104294_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112486","article-title":"Design, preparation, characterization and evaluation of five cocrystal hydrates of fluconazole with hydroxybenzoic acids","volume":"14","author":"Yu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104294_bib0016","first-page":"176","article-title":"Azilsartan-nicotinamide cocrystal: preparation, characterization and in vitro \/vivo evaluation","author":"Xiao","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104294_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2024.11.008","article-title":"Cocrystal pleomorphism-inspired drug nanoassembly for pulmonary-endothelium targeting and pulmonary hypertension treatment","author":"Zoulikha","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2026.104294_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030108","article-title":"Engineering cocrystals of poorly water-soluble drugs to enhance dissolution in aqueous medium","volume":"10","author":"Sathisaran","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2026.104294_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29102208","article-title":"New cocrystals of ligustrazine: enhancing hygroscopicity and stability","volume":"29","author":"Xie","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2026.104294_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cryst14100901","article-title":"Integrating and exploiting molecular, supramolecular, and time crystal synthons in advanced synthesis","volume":"14","author":"Chakraborty","year":"2024","journal-title":"Crystals"},{"key":"10.1016\/j.xphs.2026.104294_bib0021","series-title":"Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry","year":"2025"},{"key":"10.1016\/j.xphs.2026.104294_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2024.08.027","article-title":"Solubilization techniques used for poorly water-soluble drugs","author":"Xie","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2026.104294_bib0023","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1016\/j.arabjc.2016.03.002","article-title":"Quantitative structure activity relationships studies of non-steroidal anti-inflammatory drugs: a review","volume":"12","author":"Asirvatham","year":"2016","journal-title":"Arab J Chem"},{"key":"10.1016\/j.xphs.2026.104294_bib0024","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.partic.2021.03.015","article-title":"Co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs): insight toward formation, methods, and drug enhancement","volume":"58","author":"Nascimento","year":"2021","journal-title":"Particuology"},{"key":"10.1016\/j.xphs.2026.104294_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09247","article-title":"PEGylated aceclofenac solid lipid microparticles homolipid-based solidified reverse micellar solutions for drug delivery","volume":"8","author":"Ugwu","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.xphs.2026.104294_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.saa.2014.12.002","article-title":"Spectral and molecular modeling investigations of supramolecular complexes of mefenamic acid and aceclofenac with \u03b1- and \u03b2-cyclodextrin","volume":"174","author":"Siva","year":"2014","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.xphs.2026.104294_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144185","article-title":"Challenges and progress in nonsteroidal anti-inflammatory drugs co-crystal development","volume":"26","author":"Nugrahani","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.xphs.2026.104294_bib0028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.53879\/id.58.08.12691","article-title":"Development and evaluation of bicomponent cocrystals of aceclofenac for efficient drug delivery with enhanced solubility and improved dissolution","volume":"58","author":"Kulkarni","year":"2021","journal-title":"Indian Drugs"},{"issue":"6","key":"10.1016\/j.xphs.2026.104294_bib0029","first-page":"1288","article-title":"Synthesis and characterization of a pharmaceutical co-crystal:(aceclofenac: nicotinamide)","volume":"3","author":"Sevukarajan","year":"2011","journal-title":"J Pharm Sci Res"},{"issue":"6","key":"10.1016\/j.xphs.2026.104294_bib0030","first-page":"1389","article-title":"Screening of Aceclofenac for Cocrystallization with Nicotinamide: theoretical and Practical Perspective","volume":"84","author":"Shete","year":"2022","journal-title":"Indian J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2026.104294_bib0031","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.52711\/0974-360X.2022.00622","article-title":"Computational and experimental insights in design and development of aceclofenac co-crystals","volume":"15","author":"Mehta","year":"2022","journal-title":"RJPT"},{"issue":"8","key":"10.1016\/j.xphs.2026.104294_bib0032","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/1567201818666210218103303","article-title":"Novel aceclofenac-l-cystine and aceclofenac-urea cocrystals with enhanced oral bioavailability","volume":"18","author":"Kumar","year":"2021","journal-title":"Curr Drug Deliv"},{"issue":"8","key":"10.1016\/j.xphs.2026.104294_bib0033","doi-asserted-by":"crossref","first-page":"54","DOI":"10.53879\/id.58.08.12691","article-title":"Development and evaluation of bicomponent cocrystals of aceclofenac for efficient drug delivery with enhanced solubility and improved dissolution","volume":"58","author":"Pekamwar","year":"2021","journal-title":"Indian Drugs"},{"issue":"6","key":"10.1016\/j.xphs.2026.104294_bib0034","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2217\/nnm-2016-0405","article-title":"Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical study","volume":"12","author":"Sharma","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2026.104294_bib0035","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1021\/acs.cgd.0c00020","article-title":"Polymer-assisted aripiprazole-adipic acid cocrystals produced by hot melt extrusion techniques","volume":"20","author":"Butreddy","year":"2020","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2026.104294_bib0036","article-title":"Pharmaceutical co-crystals, salts, and co-amorphous systems: a novel opportunity of hot-melt extrusion","volume":"61","author":"Narala","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104294_bib0037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/pharmaceutics10010018","article-title":"Pharmaceutical cocrystals: new solid phase modification approaches for the formulations of APIs","volume":"10","author":"Karagianni","year":"2018","journal-title":"Pharmaceutics"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:34:36Z","timestamp":1788507276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0022354926001437"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104294","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hot melt extrusion-driven cocrystallization of aceclofenac with nicotinamide: A strategy to enhance solubility, bioavailability, and therapeutic effect","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104294"}}